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doi:10.1016/j.ejvs.2010.12.009Abstract Introduction: The aim of this study is to analyse the role of cerebral oximetry in
combination with awake testing in detecting cerebral ischaemia in patients undergoing carotid
endarterectomy (CEA) under local anaesthesia (LA).
Methods: One hundred consecutive patients scheduled for CEA under LA were investigated.
Regional oxygen saturation (rSO2) was measured with a cerebral oximeter. Cerebral ischaemia
was assessed by awake testing in conjunction with rSO2. Shunting was based solely on deteri-
oration in conscious state assessed by awake testing. The correlation between awake testing
and percentage fall in rSO2 levels was statistically analysed.
Results: Patients requiring general anaesthesia were excluded from analysis (n Z 17). Seven
patients developed deterioration in conscious state and an immediate drop in rSO2 20%
following carotid cross-clamping. Two patients requiring shunting for non-neurological reasons
were excluded from analysis. Two patients had a drop in rSO2 20%, but remained conscious
and were not shunted. There were no permanent neurological deficits postoperatively. Statis-
tical analysis showed a sensitivity of 100% with a specificity of 96% yielding a positive predictive
value of 81% and negative predictive value of 100% for a 19% drop in rSO2.
Conclusion: Cerebral oximetry using a cut off 19% drop in rSO2 has a high sensitivity and spec-
ificity when compared with awake testing.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Carotid endarterectomy (CEA) is an established treatment
of significant symptomatic1 or asymptomatic2 carotid artery3 299 3339; fax: þ44 203 299 44
s.net (H. Rashid).
ty for Vascular Surgery. Publisheocclusive disease with a peri-operative risk of stroke of
generally less than 3%.3 Cerebral hypo-perfusion and
embolisation during cross-clamping of the internal carotid
artery (ICA) are the most common causes of stroke;
therefore, monitoring of cerebral perfusion is essential.39.
d by Elsevier Ltd. All rights reserved.
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during carotid cross-clamping in CEA, but adds complexity
to the operation and may increase the risk of stroke.4
Therefore, selective shunting based on monitoring of
cerebral perfusion has been widely advocated.5
CEA is performed either under local anaesthesia (LA) or
general anaesthesia (GA) with the general anaesthesia
versus local anaesthesia for carotid surgery (GALA) trial
demonstrating similar outcome in both methods.6 LA has
the advantage of allowing assessment of cerebral perfu-
sion by awake testing of the patient’s conscious level,
thus providing a seemingly ideal base for selective
shunting.7 If selective shunting is performed, GA patients
require alternative methods of cerebral perfusion moni-
toring. Several methods have been described including
trans-cranial Doppler (TCD),8 cerebral oximetry (CO),9
electroencephalography (EEG),10 somato-sensory evoked
potentials (SSEP)11 and carotid artery stump pressure.12
However, no consensus has been found yet regarding the
best modality for cerebral perfusion monitoring.
A certain percentage of patients scheduled for CEA under
LA will require conversion to GA (9% GALA trial). Also, some
LA patients do not show immediate neurological deteriora-
tion after cross-clamping leading to delayed shunting. This
may result in patient exposure to borderline cerebral
ischaemia for longer periods than necessary and shunt
insertion under sub-optimal conditions during an advanced
state of the operation. Therefore, there continues to be
a need for a reliable method of cerebral monitoring in CEA
even for patients scheduled for LA. CO is a simple method of
measuring regional cerebral oxygen saturation (rSO2), which
appears to reflect changes in cerebral perfusion.
The objective of this study is to investigate the potential
benefit of rSO2 monitoring in patients scheduled for CEA
under LA.Table 1 Demography data and co-morbidities of all
patients scheduled for CEA under LA.
N Z 100
Age in years (median) 71
Men 81
Women 19
Diabetes mellitus 28
Hypertension 48
Ischaemic heart disease 49
Recent cerebro-vascular event 63Patients and Methods
Data of 100 consecutive patients scheduled for CEA under
LA was collected prospectively between August 2004 and
May 2009. All patients were operated on or supervised by
a single consultant surgeon in a tertiary referral centre.
Written approval was obtained from the local hospital
research and ethics committee for publication of this data.
Inclusion criterion for patients was primary CEA under LA.
All patients who seemed compliant on pre-assessment and
agreed to local anaesthesia were scheduled for the opera-
tion under LA. Indication for the operation was either
symptomatic ICA stenosis of 70% regardless of age or
asymptomatic ICA stenosis of >70% in male patients
younger than 75 years. All patients requiring GA were
excluded from the analysis.
The LA technique consisted of a superficial cervical plexus
block using 0.25% plain bupivacaine with additional local
infiltration as needed during the course of the operation.
As per the vascular team protocol, cerebral perfusion
was monitored by awake testing and trans-cranial Doppler
ultrasound (TCD). TCD (EME, Viasys, Conshohocken, PA,
USA) was performed by dedicated vascular scientists
placing the probe over the temporal bone on the side of
surgery. In patients with an adequate acoustic windowmaximum and mean middle cerebral artery flow velocity
was determined. In addition, all patients were monitored
with CO (Somanetics INVOS 4100 cerebral oximeter, Troy,
MI, USA). The oximeter electrode was placed as high up on
the forehead as possible on the ipsilateral side to the
endarterectomy. The rSO2 was recorded at 30-s intervals.
All patients underwent standard CEA. The decision for
primary or patch closure of the arteriotomy was based on
the size of the ICA measured by preoperative duplex scan.
The carotid arteries of seven patients with an ICA diameter
3.5 mm were patched.
Criteria for shunt placement were the onset of a new
neurological deficit and/or deterioration in conscious level
after carotid cross-clamping. If shunting was indicated,
a Bard Javid carotid shunt (Bard Inc., Murray Hill, NJ,
USA) was used. To enhance cerebral perfusion the intra-
operative blood pressure was maintained at or above pre-
clamp levels during clamping.
Postoperatively all patients had a clinical evaluation for
possible neurological deficits hourly for the first 6 h and
then 6 hourly until discharge.
In all patients, the rSO2 drop in percent after carotid
cross-clamping was calculated using the equation ðrSO2a
rSO2b=rSO2aÞ  100ZZrSO2% (with rSO2a equalling the
mean regional oxygen saturation between skin incision and
carotid cross-clamping and rSO2b being the regional oxygen
saturation after carotid cross-clamping). In non-shunted
patients, the mean rSO2 values were used for the calcula-
tion, whilst in shunted patients the drop in rSO2 just prior to
shunt insertion was used.
Statistical evaluation was performed via receiver oper-
ating characteristics (ROC) curve analysis using Medcalc
software (Medcalc, Mariakerke, Belgium).
Results
One hundred patients were scheduled for CEA under LA.
Sixty-three had symptomatic and thirty-seven had asymp-
tomatic ICA stenosis. The patients showed the typical
distribution for cardiovascular patients in terms of demo-
graphics and co-morbidities (Table 1). Only 86 patients were
on anti-platelet therapy on referral. Fifty-four patients were
on aspirin and 11 on clopidogrel alone. Twenty-one patients
were taking a combination (aspirin plus clopidogrel). If not
already on anti-platelet therapy, patients were started on it
following the initial consultation.
Although all patients were intended to be treated under
LA, five declined this form of anaesthetic in the operating
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had to be converted to GA intra-operatively. The main
reason was patient discomfort. All conversions occurred
before carotid cross-clamping. Patients requiring GA were
excluded from the statistical analysis. Of the 83 patients
who underwent CEA under LA, nine required shunting
(11%). In seven cases, this was needed for deterioration of
consciousness or for a new neurological deficit after carotid
cross-clamping. All of these patients immediately dropped
the rSO2 by 20% or more and suffered from a deterioration
of consciousness. However, in three patients the onset of
neurological symptoms was delayed by up to 12 min. After
shunt insertion, a significant rise in rSO2 levels was noticed
correlating with the return of cerebral perfusion. A typical
rSO2 curve for shunt patients is demonstrated in Fig. 1.
One further patient developed a hoarse voice after LA
application, which made communication difficult. A shunt
was inserted for patient safety, although there was no
neurological deficit or deterioration of consciousness.
Another patient developed severe hypertension after
clamping (>230 mm Hg systolic). This patient was normal
on awake testing and showed a drop in rSO2 of 17%.
Although neither test fulfilled the criteria for shunting, an
elective shunt was inserted to enable safe blood pressure
control. Thus, there were 83 comparisons in total with nine
patients receiving a shunt. The detailed carotid pathology
of the patients that required shunting is shown in Table 2.
None of the patients suffered from a postoperative
neurological deficit.
For CO monitoring, two false positive results were
identified. In these cases, the rSO2 dropped by more than
20%; however, the patients showed no abnormalities on
awake testing.
The ROC comparing rSO2 drop and requirement for
a shunt is shown in Fig. 2.
The percentage drop in rSO2 was compared with the
necessity for shunt in individual patient. The area under theFigure 1 Changes in rSO2% following clamping which required the
conscious state. The percentage fall in rSO22 following clamping wROC curve was 0.986 with a 95% confidence interval of
0.931e0.998. The significance level P (area Z 0.5) was
0.0001. The cut off drop of rSO2% following clamping which
indicated the need for shunt was 19%. This produced
a sensitivity of 100% and a specificity of 98% yielding
a positive predictive value of 82% and a negative predictive
value of 100%.
It was also noticed that rSO2 values and systemic blood
pressure correlated positively, with higher pressures
leading to better oxygenation values. Fig. 3 shows a typical
rSO2 curve in relation to the blood pressure. A spontaneous
drop in rSO2 below the critical 20% was reversed to 18% by
blood pressure manipulation. There was no deterioration of
consciousness at any stage.
In 25% of the patients, no appropriate temporal bone
window was identified for intra-operative TCD monitoring.
Two of these were patients that required shunting due to
deterioration of consciousness. All patients where a TCD
window was present and that required shunting showed
a relevant reduction in middle cerebral artery mean flow
(>50%) after carotid cross-clamping. However, five false
positives were identified, where the TCD flow was reduced
>50%, but the patients remained conscious and did not
require shunting. This yields a sensitivity of 58% and
a specificity of 100% with a positive predictive value of 100%
and a negative predictive value of 92%.
Discussion
Since the introduction of CEA under LA, awake testing has
been considered as an easy and reliable assessment for
critical cerebral ischaemia during carotid clamping. In view
of the equivalent outcome for both anaesthetic methods,
GA and LA, demonstrated in the GALA trial,6 the choice is
left to patient’s and/or surgeon’s preference. The current
literature fails to single out one modality as sufficiently
accurate to function as the sole method for cerebralimmediate placement of a shunt due to patient deterioration in
as 27%.
Table 2 Carotid pathology in shunted patients: Degree of ipsi- and contralateral stenosis of the internal (ICA) and external
carotid arteries (ECA).
Patient Ipsilateral Contralateral Symptomatic
ICA ECA ICA ECA
1 70% 60% 100% 80% Yes
2 70% 50% 100% n.a. No
3 70% 20% 20% 20% No
4 80% 90% 20% 90% Yes
5 70% 50% 100% 70% No
6 80% 20% 80% 50% No
7 70% 10% 30% 10% Yes
8 70% 60% 20% 10% No
9 90% 70% 90% 60% Yes
602 J.C. Ritter et al.monitoring. This may suggest that the combination of two
of the available techniques ensures the highest safety
standards.
There is no real consensus as yet on the ideal monitoring
of cerebral function for patients undergoing CEA. For all
monitoring techniques, specific advantages and disadvan-
tages have been discussed in the literature. In the last few
decades the most commonly used methods for neuro-
monitoring have been EEG and TCD13,14 often replacing
stump pressure measurement as they allow direct moni-
toring of the cerebral function/perfusion. The rSO2 moni-
toring has been introduced more recently as yet anotherFigure 2 Receiver Operator Characteristic curve: Require-
ment for a shunt based on awake testing vs. a drop in rSO2. The
best criteria for predicting loss of consciousness is a fall of rSO2
of 19% or greater and this gives a sensitivity of 100% and
a specificity of 98% yielding a positive predictive value of 80%
and the negative predictive value 100%.method.15e17 Although the hardware cost is roughly similar
(15000e20000 Euros), EEG and TCD require specialist
technician service, whilst CO is operated and interpreted
by the anaesthetist and surgeon. In times of financial and
staffing constraints in many health care systems, CO
therefore frees valuable and cost-intensive resources and
could be considered the most cost-effective method
excluding stump pressure measurement. Compared to CO
monitoring, TCD offers the added benefit of emboli
detection, which is considered important by some
authors.18e20 Both, intra-operative micro-emboli and low
cerebral flow are linked with postoperative stroke.21 Post-
operative micro-embolisation detection was used in one
study to determine the need for dextran therapy.22
However, recently, Sharpe et al.23 proposed that the peri-
operative dual anti-platelet therapy makes postoperative
monitoring for emboli unnecessary, thus minimising an
advantage of TCD over CO.
Another useful role of CO is the observed correlation
between rSO2 and blood pressure.
24 This allows the
anaesthetist to manipulate the blood pressure accord-
ingly25 and to optimise cerebral perfusion even before
deterioration of consciousness. A borderline drop in rSO2
levels may indicate impending cerebral hypo-perfusion
and, given an adequate baseline, allows the anaesthetist to
raise the blood pressure accordingly to minimise this fall.
On the other hand, if the rSO2 does not show a significant
drop, elevation of the blood pressure is not necessary, thus
minimising unnecessary myocardial stress. This effect could
be of additional interest for patients undergoing GA, which
potentially exposes them to lower than normal blood
pressure levels.
Clinical reliability of rSO2 measurement has been
compared to the established monitoring methods with
inconclusive or even contradictory results.13,19,26e28 In
a recent study, Fridell et al.29 found CO monitoring to be
inferior to TCD and EEG with a sensitivity and specificity of
68% and 94%, respectively, yielding a positive predictive
value of only 47% and a negative predictive value of 98%.
Other authors observed the opposite. In a recent study, for
example, Pugliese et al.30 reported a sensitivity and speci-
ficity of 100% for CO, outperforming TCD. However, both
studies applied different criteria as Fridell et al. used EEG as
a reference point in GA patients (n Z 323) opposed by
Pugliese et al. who used awake testing during LA procedures
Figure 3 Sudden drop in rSO2 following clamping close to the critical value of 20%. Phenylephrine infusion was used to improve
bloodpressure gradually improving rSO2. No shunt was inserted.
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detection of cerebral ischaemia in stump pressure, TCD, EEG
and CO monitoring.31 Thus, the current literature draws
a confusing picture for the role of CO in monitoring intra-
operative cerebral oxygenation. However, in an up-to-date
review, Pennekamp et al. compared the results of 14 studies
to evaluate the value of CO compared to other cerebral
monitoring techniques. They concluded that it appears to be
a promising method for cerebral monitoring during CEA,
although they acknowledged the need for further studies.32
CO has been regularly compared to TCD in previous stud-
ies29e31,33 producing differing results as reported here.
Therefore, the focus of this study was to validate CO against
the gold standard of awake testing, in which it outperformed
TCD in sensitivity and positive predictive value. We found
a lack of an adequate TCDwindow in a high percentage (25%)
of the patients, which forces the surgeon to use alternative
monitoring techniques or routine shunting in these cases.
The authors are aware that this percentage is at the upper
margin; however, all TCD assessments were performed by
dedicated vascular scientists.
Even in LA patients additional cerebral monitoring to
awake testing during CEA may be necessary, as a consider-
able percentage of patients scheduled for LA may decline
this type of anaesthesia spontaneously and prefer a primary
GA or may have to be converted to GA intra-operatively.
The analysis of our data calculated the critical rSO2
threshold at 19%, which can be rounded off to 20%, echoing
previous studies,34 although in the literature there is not
yet a clear consensus.32,35 Following clamping it was
observed that in some cases the rSO2 declines, occasionally
to near-critical levels, but then quickly recovers. This
recovery is usually associated with an increase in blood
pressure as either an autoregulatory response or iatrogenic
manipulation with vasoactive drugs.A potential dilemma represents the question whether
data obtained in this study is applicable to GA. Awake
testing gives an objective clinical account of the patient’s
cerebral function. It is therefore desirable to validate any
other monitoring techniques against this as gold standard.
Validation of any one monitoring device under GA condi-
tions can only be done against another, as awake testing as
gold standard is not available. This may explain the
contradictory findings in the literature. If a monitoring
device is validated successfully against the gold standard, it
seems reasonable that these findings are applicable to all
patients including GA procedures, although this view
remains contentious.
This recent study produces more promising results than
those of an earlier study by Samra et al.36 when comparing
rSO2 to awake testing (sensitivity 100% vs. 80%, specificity
98% vs. 82%, positive predictive value 82% vs. 33% and
negative predictive value 100% vs. 98%), despite the same
cohort size (nZ 100). A possible explanation for this is the
use of the newer generation of INVOS (4100) in this study
compared to the earlier 3100 model used by Samra et al.
This highlights the need to look at the published results of
each device separately as comparability between different
devices remains problematic due to individual value read-
ings and relative changes.37 Thus, each device may need to
be tested individually.
The lack of false negative results with the cerebral
oximeter in this study is another important benefit. One
patient who was shunted for his excessively high blood
pressures after clamping may have had underlying cerebral
hypo-perfusion. However, at the time of shunting all three
monitoring methods, awake testing, TCD and CO did not
reach the critical values or indicated cerebral ischaemia.
Interestingly in this study, three patients who required
shunting presented with delayed onset of neurological
604 J.C. Ritter et al.symptoms despite an immediate and significant rSO2 drop. In
these patients, shunting according to our rSO2 criteria would
have spared them a prolonged period of borderline cerebral
perfusion. The authors acknowledge the fact that there
were two false positive rSO2 measurements in this study that
would have exposed these two patients to unnecessary
shunting if operated under GA. However, despite sugges-
tions of an increased shunt-related stroke risk,4 evidence is
lacking38 with some surgeons preferring to shunt routinely.39
Thus, it can be argued that the application of rSO2-based
criteria in addition to awake testing is of benefit to the
patient without increasing the complication risk.
Conclusion
The results of this study suggest that CO monitoring is
a reliable method of monitoring cerebral perfusion during
CEA. In patients scheduled for CEA under LA it provides
additional safety for the indication of elective shunt
insertion and furthermore allows optimisation of cerebral
perfusion by blood pressure manipulation. However, a large
multicentre prospective trial would be desirable.
Conflict of Interest/Funding
None.
References
1 Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP,
Barnett HJCarotid Endarterectomy Trialists Collaboration.
Endarterectomy for symptomatic carotid stenosis in relation to
clinical subgroups and timing of surgery. Lancet 2004;363
(9413):915e24. 20.
2 Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al.
Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group
Prevention of disabling and fatal strokes by successful carotid
endarterectomy in patients without recent neurological symp-
toms: randomised controlled trial. Lancet 2004;363(9420):
1491e502. 8.
3 Kang JL, Chung TK, Lancaster RT, Lamuraglia GM, Conrad MF,
Cambria RP. Outcomes after carotid endarterectomy: is there
a high-risk population? A National Surgical Quality Improvement
Program report. J Vasc Surg 2009;49(2):331e8. 339.e1; discus-
sion 338e9.
4 Bond R, Rerkasem K, Rothwell PM. Routine or selective carotid
artery shunting for carotid endarterectomy (and different
methods of monitoring in selective shunting). Stroke 2003;34
(3):824e5.
5 Woodworth GF, McGirt MJ, Than KD, Huang J, Perler BA,
Tamargo RJ. Selective versus routine intraoperative shunting
during carotid endarterectomy: a multivariate outcome anal-
ysis. Neurosurgery 2007;61(6):1170e6. discussion 1176e7.
6 Lewis SC, Warlow CP, Bodenham AR, Colam B, Rothwell PM,
Torgerson D, et al. GALA Trial Collaborative Group. General
anaesthesia versus local anaesthesia for carotid surgery (GALA):
a multicentre, randomised controlled trial. Lancet 2008;372
(9656):2132e42. 20.
7 Rerkasem K, Bond R, Rothwell PM. Local versus general anaes-
thesia for carotid endarterectomy. Cochrane Database Syst Rev
2008;4:CD000126.
8 Cheung RT. Transcranial Doppler monitoring of carotid artery
occlusion during endarterectomy. Stroke 1999;30(6):1288e90.9 Murkin JM, Arango M. Near-infrared spectroscopy as an index of
brain and tissue oxygenation. Br J Anaesth 2009;103(Suppl. 1):
i3e13.
10 Tan TW, Garcia-Toca M, Marcaccio Jr EJ, Carney Jr WI,
Machan JT, Slaiby JM. Predictors of shunt during carotid
endarterectomy with routine electroencephalography moni-
toring. J Vasc Surg 2009;49(6):1374e8.
11 Fielmuth S, Uhlig T. The role of somato-sensory evoked poten-
tials in detecting cerebral ischaemia during carotid endarter-
ectomy. Eur J Anaesthesiol 2008;25(8):648e56.
12 Calligaro KD, Dougherty MJ. Correlation of carotid artery stump
pressure and neurologic changes during 474 carotid endarter-
ectomies performed in awake patients. J Vasc Surg 2005;42(4):
684e9.
13 Hans SS, Jareunpoon O. Prospective evaluation of electro-
encephalography, carotid artery stump pressure, and neuro-
logic changes during 314 consecutive carotid
endarterectomies performed in awake patients. J Vasc Surg
2007;45(3):511e5.
14 Walker RA, Fox AD, Mage TR, Horrocks M. Intraoperative duplex
scanning as a means of quality control during carotid endar-
terectomy. Eur J Vasc Endovasc Surg 1996;11(3):364e7.
15 Cuadra SA, Zwerling JS, Feuerman M, Gasparis AP, Hines GL.
Cerebral oximetry monitoring during carotid endarterectomy:
effect of carotid clamping and shunting. Vasc Endovascular Surg
2003;37(6):407e13.
16 Duncan LA, Ruckley CV, Wildsmith JA. Cerebral oximetry:
a useful monitor during carotid artery surgery. Anaesthesia
1995;50(12):1041e5.
17 Mason PF, Dyson EH, Sellars V, Beard JD. The assessment of
cerebral oxygenation during carotid endarterectomy utilising
near infrared spectroscopy. Eur J Vasc Surg 1994;8(5):590e4.
18 Ackerstaff RG, Moons KG, van de Vlasakker CJ, Moll FL,
Vermeulen FE, Algra A, et al. Association of intraoperative
transcranial doppler monitoring variables with stroke from
carotid endarterectomy. Stroke 2000;31(8):1817e23.
19 Martin KK, Wigginton JB, Babikian VL, Pochay VE,
Crittenden MD, Rudolph JL. Intraoperative cerebral high-
intensity transient signals and postoperative cognitive function:
a systematic review. Am J Surg 2009;197(1):55e63.
20 Gaunt ME, Smith JL, Ratliff DA, Bell PR, Naylor AR. A compar-
ison of quality control methods applied to carotid endarterec-
tomy. Eur J Vasc Endovasc Surg 1996;11(1):4e11.
21 Ogasawara K, Suga Y, Sasaki M, Chida K, Kobayashi K,
Otawara Y, et al. Intraoperative microemboli and low middle
cerebral artery blood flow velocity are additive in predicting
development of cerebral ischaemic events after carotid
endarterectomy. Stroke 2008;39(11):3088e91.
22 Sharpe RY, Walker J, Brown MJ, Naylor MB, Evans DH, Naylor AR.
Identifying the high-risk patient with clinically relevant embo-
lisation after carotid endarterectomy. Eur J Vasc Endovasc Surg
2009;37(1):1e7.
23 Sharpe RY, Dennis MJ, Nasim A, McCarthy MJ, Sayers RD,
London NJ et al. Dual antiplatelet therapy prior to carotid
endarterectomy reduces post-operative embolisation and
thromboembolic events: post-operative transcranial Doppler
monitoring is now unnecessary. Eur J Vasc Endovasc Surg
2010;40(2): 162e7.
24 McCleary AJ, Dearden NM, Dickson DH, Watson A, Gough MJ.
The differing effects of regional and general anaesthesia on
cerebral metabolism during carotid endarterectomy. Eur J Vasc
Endovasc Surg 1996;12(2):173e81.
25 Giustiniano E, Alfano A, Battistini GM, Gavazzeni V, Spoto MR,
Cancellieri F. Cerebral oximetry during carotid clamping: is
blood pressure raising necessary? J Cardiovasc Med (Hagers-
town) 2010;11(7):522e8.
26 Manwaring ML, Durham CA, McNally MM, Agle SC, Parker FM,
Stoner MC. Correlation of cerebral oximetry with internal
Cerebral Oximetry in Carotid Endarterectomy 605carotid artery stump pressures in carotid endarterectomy. Vasc
Endovasc Surg 2010;44(4):252e6.
27 Beese U, Langer H, Lang W, Dinkel M. Comparison of near-
infrared spectroscopy and somatosensory evoked potentials for
the detection of cerebral ischaemia during carotid endarter-
ectomy. Stroke 1998;29(10):2032e7.
28 Botes K, Le Roux DA, Van Marle J. Cerebral monitoring during
carotid endarterectomy e a comparison between electroen-
cephalography, transcranial cerebral oximetry and carotid
stump pressure. S Afr J Surg 2007;45(2):43e6.
29 Friedell ML, Clark JM, Graham DA, Isley MR, Zhang XF. Cerebral
oximetry does not correlate with electroencephalography and
somatosensory evoked potentials in determining the need for
shunting during carotid endarterectomy. J Vasc Surg 2008;48
(3):601e6.
30 Pugliese F, Ruberto F, Tosi A, Martelli S, Bruno K, Summonti D,
et al. Regional cerebral saturation versus transcranial Doppler
during carotid endarterectomy under regional anaesthesia. Eur
J Anaesthesiol 2009;26(8):643e7.
31 Moritz S,KasprzakP,ArltM,TaegerK,MetzC.Accuracyof cerebral
monitoring in detecting cerebral ischaemia during carotid
endarterectomy: a comparison of transcranial Doppler sonog-
raphy, near-infrared spectroscopy, stump pressure, and somato-
sensory evoked potentials. Anesthesiology 2007;107(4):563e9.
32 Pennekamp CW, Bots ML, Kappelle LJ, Moll FL, de Borst GJ. The
value of near-infrared spectroscopymeasured cerebral oximetry
during carotid endarterectomy in perioperative stroke preven-
tion. A review. Eur J Vasc Endovasc Surg 2009;38(5):539e45.33 Fassiadis N, Zayed H, Rashid H, Green DW. Invos Cerebral oxi-
meter compared with the transcranial Doppler for monitoring
adequacy of cerebral perfusion in patients undergoing carotid
endarterectomy. Int Angiol 2006;25(4):401e6.
34 Mille T, Tachimiri ME, Klersy C, Ticozzelli G, Bellinzona G,
Blangetti I, et al. Near infrared spectroscopy monitoring during
carotid endarterectomy: which threshold value is critical? Eur J
Vasc Endovasc Surg 2004;27(6):646e50.
35 Rigamonti A, Scandroglio M, Minicucci F, Magrin S, Carozzo A,
Casati A. A clinical evaluation of near-infrared cerebral oxi-
metry in the awake patient to monitor cerebral perfusion
during carotid endarterectomy. J Clin Anesth 2005;17(6):
426e30.
36 Samra SK, Dy EA, Welch K, Dorje P, Zelenock GB, Stanley JC.
Evaluation of a cerebral oximeter as a monitor of cerebral
ischaemia during carotid endarterectomy. Anesthesiology 2000;
93(4):964e70.
37 Yoshitani K, Kawaguchi M, Tatsumi K, Kitaguchi K, Furuya H. A
comparison of the INVOS 4100 and the NIRO 300 near-infrared
spectrophotometers. Anesth Analg 2002;94(3):586e90.
38 Aburahma AF, Stone PA, Hass SM, Dean LS, Habib J, Keiffer T,
et al. Prospective randomized trial of routine versus selective
shunting in carotid endarterectomy based on stump pressure. J
Vasc Surg 2010;51(5):1133e8.
39 Bellosta R, Luzzani L, Carugati C, Talarico M, Sarcina A. Routine
shunting is a safe and reliable method of cerebral protection
during carotid endarterectomy. Ann Vasc Surg 2006;20(4):
482e7.
